Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
NASDAQ: CORV TSX: CORV VANCOUVER, May 21, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing...
Securityholders Approve ADVANZ PHARMA Acquisition NASDAQ: CORV TSX: CORV VANCOUVER, May 15, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today...
NASDAQ: CORV TSX: CORV VANCOUVER, May 6, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Glass, Lewis & Co., LLC ("Glass Lewis"), a...
NASDAQ: CORV TSX: CORV VANCOUVER, May 4, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing...
NASDAQ: CORV TSX: CORV VANCOUVER, May 1, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), today announced that Institutional Shareholder Services Inc....
NASDAQ: CORV TSX: CORV VANCOUVER, April 8, 2020 /CNW/ - Correvio Pharma Corp. ("Correvio" or the "Company") (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing...
ADVANZ PHARMA to Acquire Correvio in a Deal Valued at US$76 Million Correvio to Hold a Meeting of Its Securityholders by No Later than May 20, 2020 Transaction Expected to Close During the Second...
NASDAQ: CORV TSX: CORV Acquisition Expected to Have a Total Purchase Price of Approximately US$76 Million Including the Repayment of Certain Correvio Indebtedness ADVANZ PHARMA Intends to Pay for the ...
NASDAQ: CORV TSX: CORV VANCOUVER and HONG KONG, March 10, 2020 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs,...
NASDAQ: CORV TSX: CORV VANCOUVER, March 2, 2020 /CNW/ - At the request of Investment Industry Regulatory Organization of Canada ("IIROC"), Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV) (the...
NASDAQ: CORV TSX: CORV VANCOUVER, Jan. 28, 2020 /CNW/ - Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), ("Correvio" or the "Company") announced today that it has received two written notifications...
NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 24, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...
NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 11, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...
NASDAQ: CORV TSX: CORV VANCOUVER, Dec. 10, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...
NASDAQ: CORV TSX: CORV VANCOUVER, Nov. 25, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...
NASDAQ: CORV TSX: CORV Post Hoc Analysis of Subset of Patients Treated in the Emergency Department Setting Safety Outcomes of Interest Observed in Less Than 1% Cases; No Deaths Reported Greater Than...
NASDAQ: CORV TSX: CORV FDA Accepts Brinavess™ New Drug Application Advisory Committee Date Set for December 10, 2019 PDUFA Date Set for December 24, 2019 Management to Host Conference Call and...
NASDAQ: CORV TSX: CORV Conference Call Scheduled for Thursday, November 14, 2019 at 8:30 a.m. Eastern (5:30 a.m. Pacific) VANCOUVER, Nov. 7, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX:...
NASDAQ: CORV TSX: CORV VANCOUVER, Nov. 4, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced...
NASDAQ: CORV TSX: CORV VANCOUVER, Sept. 27, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today...
NASDAQ: CORV TSX: CORV VANCOUVER, Sept. 12, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today...
NASDAQ: CORV TSX: CORV VANCOUVER, Sept. 4, 2019 /CNW/ - Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced ...
Safety Outcomes of Interest Observed in Less Than 1% Cases; Zero Deaths Reported Greater Than 70% of Atrial Fibrillation Episodes Successfully Converted to Sinus Rhythm in a Median Time of 12 Minutes ...
FDA Accepts New Drug Application for BrinavessTM; PDUFA Date Set for December 24, 2019 Recently Strengthened Balance Sheet Extends Cash Runway Into Mid-2020 Management to Host Conference Call and...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.